XML 36 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
OPERATING LEASE RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS
12 Months Ended
Mar. 31, 2024
Operating Lease Right-of-use Assets And Lease Obligations  
OPERATING LEASE RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS

12. OPERATING LEASE RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS

 

The Company has one operating lease primarily for office and administration.

 

During December 2021, the Company entered into a new lease agreement. The Company paid $85,000 deposit that would be returned at the end of the lease. In December 2022, the Company started a new lease with an additional suite in the same premise as the existing lease.

 

When measuring the lease obligations, the Company discounted lease payments using its incremental borrowing rate. The weighted-average-rate applied is 11.4%.

 

   2024   2023 
Right of Use Asset  $   $ 
Beginning balance at March 31   1,587,492    1,242,700 
New leases   -    685,099 
Amortization   (365,899)   (340,307)
Ending balance at March 31   1,221,593    1,587,492 

 

   2024   2023 
Lease Liability  $   $ 
Beginning balance at March 31   1,722,095    1,330,338 
New leases   -    685,099 
Repayment and interest accretion   (335,609)   (293,342)
Ending balance at March 31   1,386,486    1,722,095 
           
Current portion of operating lease liability   457,371    335,608 
Noncurrent portion of operating lease liability   929,115    1,386,487 

 

The operating lease expense was $564,167 for the year ended March 31, 2024 (2023: $405,496) and included in the selling, general and administrative expenses. Operating cash flows from operating leases amounted to $509,041 and $341,558 during the years ended March 31, 2024 and March 31, 2023, respectively.

 

The following table represents the contractual undiscounted cash flows for lease obligations as at March 31, 2024:

 

Calendar year  $ 
2024   552,293 
2025   600,288 
2026   565,359 
2027 and beyond   - 
Total undiscounted lease liability   1,717,940 
Less imputed interest   (331,454)
Total   1,386,486 

 

 

BIOTRICITY INC.

Notes to Consolidated Financial Statements

Years ended March 31, 2024 and 2023

(Expressed in US Dollars)